Cytisinicline Nears FDA Decision: First New Smoking Cessation Drug in Two Decades
With PDUFA date set for June 20, 2026, cytisinicline could become the first novel smoking cessation pharmacotherapy approved by FDA in nearly 20 years.
April 14, 20265 min read
